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Introduction
Gait speed, measured with the time taken to walk 4 m at fast and usual gait speeds, is an important geriatric measurement that indicates age-related decline in physical and cognitive function [1] [2] [3] [4] among older adults. Previous epidemiological studies demonstrated that gait speed was an independent predictor for cognitive impairment [1] [2] [3] [4] . Specifically, the temporal sequence between slower gait speed and cognitive decline has been confirmed [1, [3] [4] [5] [6] .
Obstructive sleep apnoea (OSA) among older adults and the slower gait speed share a common attribute of muscle ageing. Characterised as nocturnal intermittent hypoxia during sleep [7] , OSA in older adults is primarily attributable to airway collapse due to muscle ageing [8] , whereas OSA in younger adults is mostly due to a sensitive ventilator control [8] . Epidemiological studies showed that OSA is more prevalent in older adults than in younger adults [9] . OSA has been indicated to have strong associations with brain structural changes such as cerebral white matter change (WMC) [10] and functional changes such as cognitive impairment [7, 11] . We previously reported that middle-aged and older adults with OSA were likely to have a 2-fold increased risk of WMC compared with those without OSA [10] .
However, no study has yet investigated the modifying effect of OSA status on the association between gait speed and cognitive impairment in a large general population. Therefore, we aimed to examine the interaction according to OSA on the association between slower gait speed and cognitive impairment among 2,222 well-functioning community-dwelling adults. We hypothesised that individuals with OSA would be at substantially higher risk of cognitive impairment associated with slow gait speed than those without OSA. To test this hypothesis, we utilised the Korean Genome and Epidemiology Study (KoGES) data.
Methods

Study population
The KoGES cohort, an ongoing prospective cohort study, was initiated in 2001 to evaluate the risk and the burden of chronic diseases among the general population. Detailed information on the KoGES cohort has been previously published [12] . Briefly, at baseline enrolment from 2001 to 2002, the initial cohort of 5,020 adults aged 40-69 years in Ansan, South Korea was randomly recruited by telephone contact with 10,957 individuals [12] . Because the penetration of telephone lines in Ansan was very high, recruitment using a telephone directory allows for random selection to enrol a representative sample from the general population [12] . According to demographic characteristics such as age and gender of the 2000 census, the cohort was recruited with a two-stage cluster sampling, comprising 2,523 men (50.26%) and 2,497 women (49.74%). Since then, the study participants have been biennially followed up. During their visits, the participants underwent comprehensive tests including a physical examination, an interviewer-administrated questionnaire, and biochemical and clinical examinations. Research staff members were professionally trained on standardised protocols. The study participants, wearing light clothing without shoes, were measured for height and weight. Venipuncture was performed on all participants early in the morning at each visit after at least 8 h of fasting. The blood samples were sent to the Seoul Clinical Laboratory (Seoul, South Korea). All participants signed an informed consent form. The current study abided by the ethical rules for human research stated in the Declaration of Helsinki. The Human Subjects Review Committee and the Institutional Review Board of our research centre approved this study.
As a sub-study for ageing, geriatric measurements including a cognitive test, sleep polysomnography and a motor test were initiated and followed up every 4 years starting from the 6th follow-up visit (16 February 2011 to 27 December 2014). Of 3,052 participants who visited at the 6th follow-up, we excluded 466 participants due to incomplete data on cognitive test, gait test or sleep polysomnography. Of 2,586 participants who completed all three tests, we further excluded 60 participants who had been diagnosed with dementia (n = 5) or stroke (n = 55). Additionally, 304 participants were excluded due to missing covariates (291 smoking, 11 diabetes and 2 educational information). Thus, a total of 2,222 participants (942 men and 1,280 women) aged 50-80 years were in the final analyses.
Gait speed
Measurement of the time taken to walk a 4-m course was utilised to ascertain gait speed. All participants were asked to walk a 4-m course along the hallway at fast (maximum) and usual gait speeds. Using a stopwatch, a research staff member recorded the time taken by each participant to walk from the starting point to the end point of the 4-m course. We calculated the speed (m/s) by dividing the 4-m distance by the time taken to walk in seconds. For example, if a participant walked at slow speed across 4 m, then the participant would have a lower gait speed and a longer time to walk 4 m. The measurement of gait speed was introduced by the National Institute of Health (NIH) as a comprehensive geriatric assessment tool [13] . The reliability of the gait speed has been validated [14] .
Polysomnography
An overnight polysomnography test was assessed with the Embla portable sleep monitoring system (Embletta ® X100, Embla, USA). Apnoeas and hypopnoeas were ascertained according to the guideline from the American Academy of Sleep Medicine [15] . The apnoea-hypopnoea index (AHI) was determined by averaging the number of events per hour. OSA was defined as having AHI ≥15. These polysomnography data were scored by two professionally trained technicians with more than 5 years of experience. Both the intra-rater reliability for two raters (Cronbach's α = 0.996 and 1.00) and the inter-rater reliability for AHI were high (Cronbach's α = 0.998).
Cognitive measurement
The Mini-Mental State Examination (MMSE), the most widely used global cognitive screening test [16] , has been used not only in clinical evaluations but also in research for the diagnosis of mild cognitive impairment or dementia, particularly to screen individuals at the high risk of cognitive impairment. The K-MMSE, validated in the Korean language [17] , has a maximum possible score of 30.
Statistical analysis
T-test, analysis of variance and chi-square test were utilised to examine the continuous and categorical variables of descriptive characteristics. Kruskal-Wallis tests were used to compare categorical variables. The significance of trend according to the tertile categories of gait speed was examined. To assess the associations, multivariable linear regression models were established after adjusting for the following potential confounding variables: age, sex, body mass index (BMI), education, current smoker, current drinker, physical activity, hypertension, diabetes, total cholesterol, high-sensitivity C-reactive protein (hs-CRP) and depression (Beck's Depression Index, BDI). To control for potential influence from height on gait speed, we additionally adjusted for height. A two-sided P value of <0.05 was considered significant. SAS version 9.3 (SAS Institute Inc., Cary, NC, USA) was performed for all the statistical analyses.
Results
General characteristics according to the tertile range of the time taken to walk 4 m Table 1 presents the general characteristics based on the tertile range of the time taken to walk 4 m at a usual gait speed among 2,222 participants (942 men and 1,280 women). As the time taken to walk 4 m (s) increased, the gait speed (m/s) decreased. According to the tertile range, the average age of the participants showed an increasing trend (P value for trend <0.001). A slower gait speed was associated more with women than with men (P < 0.001). Those with slower gait speed were more likely to have higher BMI (P = 0.016), higher systolic blood pressure (P < 0.001), higher frequency of hypertension (P < 0.001) and diabetes (P < 0.001).
Unexpectedly, a slower gait speed was associated with individuals who drank less (P < 0.001) and smoked less (P = 0.001). This might indicate behavioural changes followed by changes in health status including muscle ageing. Those with a slower gait speed had a higher level of hs-CRP (P = 0.037), higher depression index (P < 0.001) and a lower K-MMSE score (P < 0.001).
General characteristics of the study participants according to OSA Table 2 lists the descriptive characteristics of the 2,222 study participants according to OSA status. Compared with participants without OSA, participants with OSA were more likely to be older (P < 0.001) and male (P < 0.001). They also had a higher BMI (P < 0.001), higher systolic (P < 0.001) and higher diastolic blood pressure (P < 0.001). The frequency of current drinkers and current smokers among participants with OSA was higher (P = 0.005 and P < 0.001, respectively). The participants with OSA had a higher prevalence of hypertension and diabetes (both P < 0.001).
The level of hs-CRP was higher among the participants with OSA (P < 0.001). The individuals with OSA had a lower depression index (P = 0.027). Importantly, the cognitive functional score, measured with K-MMSE, was significantly lower in those with OSA than in those without OSA (P = 0.017). However, OSA caused no difference in the walking time (P = 0.082 at fast gait speed and P = 0.082 at usual gait speed).
Significantly modifying effect according to OSA on the association between the time taken to walk 4 m and a cognitive impairment Table 3 presents a significantly modifying effect according to OSA on the associations between the time taken to walk 4 m at fast and usual gait speeds and the cognitive functional score, measured with K-MMSE among 2,222 participants. Particularly, significant inverse associations between the time taken to walk the 4-m course and cognitive impairment were substantially higher among those with OSA, compared with those without OSA (β = −0.70 versus β = −0.21, P value for interaction = 0.003 at fast gait speed; β = −0.40 versus β = −0.13, P value for interaction = 0.007 at usual gait speed) (Table 3 and Appendix 2, see Supplementary data, available at Age and Ageing online). Even after adjusting for height, the associations between the time taken to walk the 4 m and cognitive impairment remained significant in both total and OSA populations (Appendix 1, see Supplementary data, available at Age and Ageing online). 
Discussion
In a population-based cross-sectional study among wellfunctioning community-dwelling adults, we observed that a cognitive functional score had a significantly inverse association with the time taken to walk 4 m at both fast and usual gait speeds, after adjusting for age, sex, BMI, education, smoking, drinking, physical activity, hypertension, diabetes, total cholesterol, hs-CRP and depression. Furthermore, we found that this association between the time taken to walk 4 m and cognitive impairment was significantly modified by OSA status. Even after adjusting for potential confounding factors, the significant interaction by OSA remained. To the best of our knowledge, this is the first study to investigate whether or not the association between slower gait speed and cognitive functional impairment would be aggravated if an individual had OSA. Our current findings in a general population may help us better understand the mechanism of cognitive impairment associated with slow gait speed.
Our findings are consistent with previous findings that demonstrate significant associations with both slower pace of gait speed [1, [3] [4] [5] [6] and OSA [7, 11] on cognitive impairment. A 6-year longitudinal study among 108 healthy adults aged 65 years or older found that the walking time (30 ft) significantly predicted cognitive impairment, measured by MMSE (P = 0.009) [1] . A previous report by the Health, Ageing, and Body Composition Study demonstrated the association between slower gait speed and cognitive functional decline [18] .
Only one previous study examined the effect of gait abnormalities among OSA patients before and after 8-week treatments of continuous positive airway pressure (CPAP), which is a primary clinical treatment for OSA patients to alleviate upper airway obstruction [19] . That study found a substantial but non-significant improvement in gait speed [19] . Particularly, previous studies demonstrated that OSA had a strong association with cognitive impairment [11] , particularly due to the lesions in a prefrontal subcortical region [20] which is in control of motor coordination function [21] . Furthermore, a recent meta-analysis with 13 clinical trials revealed that OSA patients with CPAP treatment exhibited a significant improvement on cognitive function related to vigilance [22] . Physical activity has been reported to be beneficial in delaying cognitive impairment [23] .
The aetiology for cognitive decline linked to slower gait speed has not fully elucidated. However, previous findings suggested that slower gait speed is attributable to lesions in the prefrontal area [20] , which is responsible for both cognitive and motor functions [21] . The lesions resulted from agerelated changes that cause brain structural changes such as volumetric atrophy [24] and age-related WMC [25] . These changes subsequently lead to increased inflammation [25] . Moreover, it has been proposed that cognitive decline associated with OSA, characterised by nocturnal intermittent hypoxia [7] , may be linked to a lack of oxygen supply, which leads to increased oxidative stress and inflammation [26] . Oxidative stress is regarded as a contributor to skeletal muscle ageing such as muscle atrophy [27] . Furthermore, a recent finding from an animal study with mice showed that the intermittent hypoxia in OSA causes increased inflammatory markers [28] , which further affect cognitive impairment. In this regard, neurocognitive deficits due to increased oxidative stress or inflammation may have an impact on cognitive functional impairment [29] .
Older individuals commonly experience gait speed decline as their skeletal muscle ages. In addition, these adults are at high risk of OSA. Both slow gait speed and OSA from muscle ageing increase the risk of cognitive functional impairment. Thus, with the overlapped underlying mechanisms on slower gait speed and OSA linked to cognitive impairment, it is important to identify older adults who might be at an early stage of cognitive impairment by assessing gait speed as well as by diagnosing OSA. Our findings in the current study provide a better understanding of the relationship between gait speed and OSA caused by muscle ageing in an older population in order to ultimately mitigate the burden generated from mild cognitive impairment.
The response rate at baseline indicates data quality necessary to ensure a representative sample, so that the study results can extend to the target population of interest. As previously reported [12] , the KoGES has two study sites. Ansan, the current study site, is an urbanised area and the 5,020 participants were enroled through telephone contacts with 10,957 individuals (a response rate of 45.82%). The second site, Ansung, is a rural area and 2,240 men and 2,780 women were enroled through attempts to contact 7,192 individuals by mails, door-to-door visits and telephone calls (a response rate by 69.80%). The response rate of Ansan was lower than that of Ansung. However, the study participants were randomly selected from the telephone directory for the general population, so the representativeness of the study population should be valid. Furthermore, to retain valid representativeness, the study participants were randomly selected from the sampling based on the sex and gender distribution.
This ageing sub-study initiated from the 6th follow-up visit of a longitudinal cohort study indispensably has individuals lost to follow-up from the initial cohort. By comparing the general characteristics between the initial cohort participants and the individuals who completed the 6th follow-up, we confirmed no significant difference in age, BMI, education, the prevalence of hypertension and physical activity (Appendix 3, see Supplementary data, available at Age and Ageing online). Therefore, we were certain that the missing data were MCAR (missing completely at random) and did not utilise imputation data.
This study has several strengths. First, our study is a large population-based study that has a large sample size from the general population. Second, the participants in the current study were well-functioning community-dwelling older adults without stroke, dementia or head injury. This allowed us to investigate the early stages of physical and cognitive functional impairment. However, this study has also limitations taken into account when interpreting our findings. First, we utilised a cross-sectional study design, which may not infer causality. Second, as a limitation of MMSE, ceiling effects might have affected to be lack of sensitivity to discern cognitive deterioration among healthy participants with early-stage cognitive impairment [30] . However, this potential insensitivity of MMSE among healthy ageing participants did not affect the participants with and without slow gait differently. Thus, the results could only have been underestimated; it supports our findings.
In conclusion, in this population-based cross-sectional study of 2,222 participants, we found a significant inverse association between the time taken to walk 4 m and cognitive function, even after adjusting for potential confounding variables. Furthermore, the association between slower walking time and cognitive impairment became substantially stronger, if an individual had OSA.
Key points
• Older adults are known to have higher prevalence of obstructive sleep apnoea (OSA) than younger adults.
• The diagnosis of OSA among older adults was primarily attributable to airway collapse due to muscle ageing.
• Slow gait has been known to be associated with cognitive impairment.
Supplementary data
Supplementary data are available at Age and Ageing online.
